We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVOP
1501
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$401K ﹤0.01%
17,582
SCHL icon
1502
Scholastic
SCHL
$784M
$401K ﹤0.01%
13,390
GVA icon
1503
Granite Construction
GVA
$5.41B
$400K ﹤0.01%
20,910
SBSI icon
1504
Southside Bancshares
SBSI
$984M
$400K ﹤0.01%
14,418
+1,487
+11% +$42.2K
TSE
1505
DELISTED
Trinseo
TSE
$399K ﹤0.01%
17,985
CHCT
1506
Community Healthcare Trust
CHCT
$433M
$398K ﹤0.01%
9,740
+1,403
+17% +$52.5K
OMER icon
1507
Omeros
OMER
$1.26B
$397K ﹤0.01%
26,984
+5,524
+26% +$82.5K
SMP icon
1508
Standard Motor Products
SMP
$870M
$397K ﹤0.01%
9,638
HOUS
1509
DELISTED
Anywhere Real Estate
HOUS
$395K ﹤0.01%
53,362
+10,507
+25% +$54.2K
IPAR icon
1510
Interparfums
IPAR
$3.7B
$394K ﹤0.01%
8,191
ATRI
1511
DELISTED
Atrion Corp
ATRI
$394K ﹤0.01%
618
KURA icon
1512
Kura Oncology
KURA
$896M
$393K ﹤0.01%
24,108
+10,456
+77% +$151K
VIE
1513
DELISTED
Viela Bio, Inc. Common Stock
VIE
$392K ﹤0.01%
9,054
+6,274
+226% +$284K
BLMN icon
1514
Bloomin' Brands
BLMN
$924M
$391K ﹤0.01%
36,722
VSTO
1515
DELISTED
Vista Outdoor Inc.
VSTO
$391K ﹤0.01%
27,041
SAFE
1516
Safehold
SAFE
$1.1B
$390K ﹤0.01%
6,497
+1,596
+33% +$80.4K
DCH
1517
Dauch Corp
DCH
$1.6B
$389K ﹤0.01%
51,196
LTHM
1518
DELISTED
Livent Corporation
LTHM
$389K ﹤0.01%
63,109
ACLS icon
1519
Axcelis
ACLS
$4.42B
$388K ﹤0.01%
13,934
PRIM icon
1520
Primoris Services
PRIM
$4.35B
$387K ﹤0.01%
21,802
+3,822
+21% +$60.3K
RCUS icon
1521
Arcus Biosciences
RCUS
$3.67B
$387K ﹤0.01%
15,645
BGC icon
1522
BGC Group
BGC
$5.2B
$385K ﹤0.01%
+140,594
New +$389K
TVTX icon
1523
Travere Therapeutics
TVTX
$5.79B
$385K ﹤0.01%
18,842
NP
1524
DELISTED
Neenah, Inc. Common Stock
NP
$383K ﹤0.01%
7,745
CEVA icon
1525
CEVA Inc
CEVA
$855M
$381K ﹤0.01%
10,183

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.